Genomictree Statistics

Total Valuation

Genomictree has a market cap or net worth of KRW 377.12 billion. The enterprise value is 283.56 billion.

Market Cap	377.12B
Enterprise Value	283.56B

Important Dates

The last earnings date was Tuesday, March 18, 2025.

Earnings Date	Mar 18, 2025
Ex-Dividend Date	n/a

Share Statistics

Genomictree has 23.99 million shares outstanding. The number of shares has decreased by -9.92% in one year.

Current Share Class	n/a
Shares Outstanding	23.99M
Shares Change (YoY)	-9.92%
Shares Change (QoQ)	+1.48%
Owned by Insiders (%)	16.03%
Owned by Institutions (%)	5.34%
Float	20.15M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	158.90
PB Ratio	3.04
P/TBV Ratio	3.08
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-27.68
EV / Sales	120.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-17.59

Financial Position

The company has a current ratio of 20.56, with a Debt / Equity ratio of 0.02.

Current Ratio	20.56
Quick Ratio	20.35
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.13
Interest Coverage	-51.97

Financial Efficiency

Return on equity (ROE) is -8.33% and return on invested capital (ROIC) is -7.56%.

Return on Equity (ROE)	-8.33%
Return on Assets (ROA)	-7.26%
Return on Invested Capital (ROIC)	-7.56%
Return on Capital Employed (ROCE)	-12.16%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.02
Inventory Turnover	7.48

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.29% in the last 52 weeks. The beta is 0.01, so Genomictree's price volatility has been lower than the market average.

Beta (5Y)	0.01
52-Week Price Change	-31.29%
50-Day Moving Average	18,065.20
200-Day Moving Average	18,545.90
Relative Strength Index (RSI)	29.65
Average Volume (20 Days)	198,855

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Genomictree had revenue of KRW 2.36 billion and -10.24 billion in losses. Loss per share was -429.00.

Revenue	2.36B
Gross Profit	-745.56M
Operating Income	-15.31B
Pretax Income	-10.39B
Net Income	-10.24B
EBITDA	-14.12B
EBIT	-15.31B
Loss Per Share	-429.00

Full Income Statement

Balance Sheet

The company has 96.08 billion in cash and 2.08 billion in debt, giving a net cash position of 94.00 billion or 3,918.30 per share.

Cash & Cash Equivalents	96.08B
Total Debt	2.08B
Net Cash	94.00B
Net Cash Per Share	3,918.30
Equity (Book Value)	124.32B
Book Value Per Share	5,163.99
Working Capital	92.91B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -13.63 billion and capital expenditures -2.48 billion, giving a free cash flow of -16.12 billion.

Operating Cash Flow	-13.63B
Capital Expenditures	-2.48B
Free Cash Flow	-16.12B
FCF Per Share	-671.85

Full Cash Flow Statement

Margins

Gross Margin	-31.56%
Operating Margin	-648.24%
Pretax Margin	-439.79%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Genomictree does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	9.92%
Shareholder Yield	9.92%
Earnings Yield	-2.72%
FCF Yield	-4.27%

Stock Splits

The last stock split was on September 14, 2018. It was a forward split with a ratio of 2.

Last Split Date	Sep 14, 2018
Split Type	Forward
Split Ratio	2

Scores

Genomictree has an Altman Z-Score of 45.17.

Altman Z-Score	45.17
Piotroski F-Score	n/a